BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32077315)

  • 1. Novel Biomarkers for Evaluation of Endothelial Dysfunction.
    Leite AR; Borges-Canha M; Cardoso R; Neves JS; Castro-Ferreira R; Leite-Moreira A
    Angiology; 2020 May; 71(5):397-410. PubMed ID: 32077315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
    Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.
    Elkamshoushi AAM; Hassan EM; El Abd AM; Hassan SZ; Maher AA
    Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim.
    Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H
    Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
    Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
    Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke.
    He XW; Ke SF; Bao YY; Hong WJ; Shen YG; Li C; Zhu F; Wang E; Jin XP
    Clin Chim Acta; 2018 Mar; 478():157-161. PubMed ID: 29287901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
    Ozalper V; Kara M; Tanoglu A; Cetındaglı I; Ozturker C; Hancerlı Y; Hıra S; Kara K; Beyazıt Y; Yazgan Y
    Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Endocan, Ischemia-Modified Albumin, and hsCRP Levels With Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Balamir I; Ates I; Topcuoglu C; Turhan T
    Angiology; 2018 Aug; 69(7):609-616. PubMed ID: 29172652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble endoglin, hypercholesterolemia and endothelial dysfunction.
    Rathouska J; Jezkova K; Nemeckova I; Nachtigal P
    Atherosclerosis; 2015 Dec; 243(2):383-8. PubMed ID: 26520890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of endothelial activation and dysfunction in cardiovascular diseases.
    Zhang J
    Rev Cardiovasc Med; 2022 Feb; 23(2):73. PubMed ID: 35229564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
    Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
    Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
    Ağaç MT; Kahyaoğlu B; Aksoy MMN; Cinemre FB; Vatan MB; Gündüz Y
    Anatol J Cardiol; 2019 Feb; 21(2):76-82. PubMed ID: 30694799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of apelin, endoglin and endocan with diabetic peripheral neuropathy in type 2 diabetic patients.
    Bilir B; Ekiz Bilir B; Yilmaz I; Soysal Atile N; Yildirim T; Kara SP; Gumustas SA; Orhan AE; Aydin M
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):892-8. PubMed ID: 27010147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Microparticles Are Elevated in Treated HIV -1 Infection and Are Deleterious to Endothelial Cell Function.
    Hijmans JG; Stockelman KA; Garcia V; Levy MV; Brewster LM; Bammert TD; Greiner JJ; Stauffer BL; Connick E; DeSouza CA
    J Am Heart Assoc; 2019 Feb; 8(4):e011134. PubMed ID: 30779672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K; Mysliwiec M; Pawlak D
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo.
    Cox LA; van Eijk LT; Ramakers BP; Dorresteijn MJ; Gerretsen J; Kox M; Pickkers P
    Shock; 2015 Apr; 43(4):322-6. PubMed ID: 25565643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute insulin-induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes.
    Al-Qaissi A; Papageorgiou M; Deshmukh H; Madden LA; Rigby A; Kilpatrick ES; Atkin SL; Sathyapalan T
    Diabetes Obes Metab; 2019 Mar; 21(3):533-540. PubMed ID: 30264480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Endocan Levels.
    Balta Ş
    Angiology; 2021 Mar; 72(3):209. PubMed ID: 33086860
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence].
    Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F
    Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.